CARDIOPOLYMERS
CardioPolymers is a developer of an implantable device for treating congestive heart failure. It provides biocompatible polymer implant therapies to handle chronic heart failure, mitral valve regurgitation, and postoperative atrial fibrillation.
CARDIOPOLYMERS
Industry:
Health Care Medical Medical Device
Founded:
2002-05-14
Address:
Laguna Hills, California, United States
Country:
United States
Status:
Active
Similar Organizations
More informations about "CardioPolymers"
CardioPolymers - Crunchbase Company Profile & Funding
Organization. CardioPolymers . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. CardioPolymers is a developer of an implantable device โฆSee details»
CardioPolymers Company Profile 2024: Valuation, Investors
CardioPolymers General Information Description. Developer of an implantable device for treating congestive heart failure. The company provides biocompatible polymer implant therapies to โฆSee details»
CardioPolymers, Inc. - Drug pipelines, Patents, Clinical trials
Explore CardioPolymers, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
CardioPolymers - Products, Competitors, Financials, Employees ...
CardioPolymers, formerly Symphony Medical, is a development-stage company focused on novel biocompatible polymer implant therapies to treat cronic heart failure, mitral valve regurgitation โฆSee details»
Lonestar Heart acquires CardioPolymers - 2010-06-02 - Crunchbase
CardioPolymers CardioPolymers is a developer of an implantable device for treating congestive heart failure. Acquiring Organization: Lonestar Heart LoneStar Heart is a biomedical company โฆSee details»
CardioPolymers - Crunchbase
CardioPolymers is a developer of an implantable device for treating congestive heart failure.See details»
Intelligent biomaterials for cardiovascular applications
Dec 1, 2023 Cardiovascular disease (CVD) is a generic term for conditions affecting the heart and blood vessels [1].These conditions range from coronary artery disease causing angina or โฆSee details»
Bioengineering approaches to treat the failing heart: from ... - Nature
Aug 27, 2021 In this Review, Dvir and colleagues summarize and discuss the state-of-the-art technologies that enable the bioengineering of functional cardiac tissues and discuss current โฆSee details»
Biomaterials in Cardiovascular Research: Applications and Clinical ...
May 8, 2014 Cardiovascular biomaterials (CB) dominate the category of biomaterials based on the demand and investments in this field. This review article classifies the CB into three major โฆSee details»
Alginate Application for Heart and Cardiovascular Diseases
Nov 30, 2017 Dvir et al. developed 3D nanocomposites of gold nanowires (NW) within macroporous alginate scaffolds, which functioned as a bridge between the nonconducting pore โฆSee details»
Microplastics and Nanoplastics in Atheromas and Cardiovascular โฆ
Mar 6, 2024 A total of 304 patients were enrolled in the study, and 257 completed a mean (±SD) follow-up of 33.7±6.9 months. Polyethylene was detected in carotid artery plaque of 150 โฆSee details»
Conductive polymers for cardiac tissue engineering and โฆ
Cardiovascular diseases, such as myocardial infarction, are considered a significant global burden and the leading cause of death. Given the inability of damaged cardiac tissue to self-repair, โฆSee details»
Polymeric Biomaterials for the Treatment of Cardiac Post โฆ
Jul 7, 2021 PLGA microparticles were used as a carrier of growth factors to simulate cell proliferation and organization in vessels . When applied in cardiac regeneration, PLGA โฆSee details»
Elastomeric Polyesters in Cardiovascular Tissue Engineering and โฆ
Aug 28, 2023 Cardiovascular tissue constructs provide unique design requirements due to their functional responses to substrate mechanical properties and cyclic stretching behavior of โฆSee details»
Polymers in Cardiology - SpringerLink
Jan 1, 2014 Polymers as Coating Matrices for Drug-Coated Balloons (DCB) As alternative to DES DCB were developed since it was found that a single short exposure to PTX using non โฆSee details»
Supramolecular polymer materials bring restorative heart valve โฆ
Jan 1, 2022 An alternative approach is to make use of the natural healing capacity of the human body by providing bioabsorbable materials that with time are replaced by new tissue built by โฆSee details»
Natural Polymers in Heart Valve Tissue Engineering: Strategies ...
Scaffolds intended for heart valve tissue engineering face additional distinct challenges owing to their direct contact with blood. Specifically, the construct should be resistant to calcification, โฆSee details»
Biomaterial applications in cardiovascular tissue repair and ...
The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials โฆSee details»
Biomaterials in Cardiovascular Research: Applications and Clinical ...
Classification of cardiovascular biomaterial. 3.1. Metals and Alloys. Metals have been used for more than a century in biomedical field [].The use of metals in cardiovascular applications โฆSee details»
Stent Polymers | Circulation: Cardiovascular Interventions
May 18, 2016 The necessity of polymers on drug-eluting stent (DES) platforms is dictated by the need of an adequate amount and optimal release kinetic of the antiproliferative drugs for โฆSee details»